X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14) 14
animals (12) 12
antibodies, monoclonal - immunology (12) 12
index medicus (12) 12
antibodies, neutralizing - immunology (11) 11
viruses (10) 10
monoclonal antibodies (9) 9
antibodies, viral - immunology (7) 7
infections (7) 7
multidisciplinary sciences (7) 7
female (6) 6
health aspects (6) 6
immunology (6) 6
mice (6) 6
antibodies, neutralizing - isolation & purification (5) 5
immunoglobulin g - immunology (5) 5
infection (5) 5
influenza (5) 5
monoclonal-antibodies (5) 5
vaccines (5) 5
amino acid sequence (4) 4
antibodies (4) 4
antibodies, monoclonal - isolation & purification (4) 4
antibodies, viral - isolation & purification (4) 4
b-cells (4) 4
crystallography, x-ray (4) 4
hemagglutinin glycoproteins, influenza virus - immunology (4) 4
immunoglobulins (4) 4
influenza, human - immunology (4) 4
male (4) 4
memory b-cells (4) 4
molecular sequence data (4) 4
neutralization (4) 4
research (4) 4
virology (4) 4
virus (4) 4
virus diseases (4) 4
acquired immune deficiency syndrome--aids (3) 3
aids (3) 3
antibodies, monoclonal - administration & dosage (3) 3
antibodies, monoclonal - therapeutic use (3) 3
antibodies, neutralizing - administration & dosage (3) 3
antigenic determinants (3) 3
competition (3) 3
cross reactions - immunology (3) 3
disease models, animal (3) 3
enzyme-linked immunosorbent assay (3) 3
epitopes - immunology (3) 3
glycoproteins (3) 3
hiv (3) 3
hiv antibodies - immunology (3) 3
hiv-1 - immunology (3) 3
immunization (3) 3
in-vivo (3) 3
influenza, human - virology (3) 3
models, molecular (3) 3
mutation (3) 3
mutation - genetics (3) 3
neutralizing antibodies (3) 3
prevention (3) 3
protein binding (3) 3
protein conformation (3) 3
proteins (3) 3
research article (3) 3
vaccination (3) 3
acquired immune deficiency syndrome (2) 2
adult (2) 2
analysis (2) 2
anti-stem antibody (2) 2
antibodies, monoclonal - chemistry (2) 2
antibodies, monoclonal - metabolism (2) 2
antibodies, neutralizing - chemistry (2) 2
antibodies, neutralizing - metabolism (2) 2
antibodies, viral - administration & dosage (2) 2
antibodies, viral - therapeutic use (2) 2
antibody specificity (2) 2
antibody-dependent cell cytotoxicity - immunology (2) 2
antigens (2) 2
antigens, viral - immunology (2) 2
article (2) 2
b cells (2) 2
binding sites (2) 2
biological sciences (2) 2
biology (2) 2
cancer (2) 2
care and treatment (2) 2
cells, cultured (2) 2
cho cells (2) 2
complex (2) 2
control (2) 2
cricetinae (2) 2
cricetulus (2) 2
cross protection - immunology (2) 2
crystallization (2) 2
cytomegalovirus (2) 2
dogs (2) 2
enhanced disease (2) 2
epitope (2) 2
estructura cristal·lina (2) 2
fc receptor (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 12/2014, Volume 516, Issue 7531, pp. 418 - 422
Journal Article
Science, ISSN 0036-8075, 8/2011, Volume 333, Issue 6044, pp. 850 - 856
The isolation of broadly neutralizing antibodies against influenza A viruses has been a long-sought goal for therapeutic approaches and vaccine design. Using a... 
Influenza A virus | RESEARCH ARTICLES | Vaccination | Blood donation | Antibodies | Plasma cells | Viruses | Cultured cells | Cultural groups | Infections | Monomers | MEMBRANE-FUSION | B-CELLS | SITE | COMPLEX | EPITOPE | SEQUENCES | SUBTYPES | MULTIDISCIPLINARY SCIENCES | VIRUS HEMAGGLUTININ | MONOCLONAL-ANTIBODIES | RECEPTOR-BINDING | Influenza A Virus, H1N1 Subtype - immunology | Orthomyxoviridae Infections - prevention & control | Antibody Specificity | Humans | Protein Multimerization | Molecular Sequence Data | Crystallography, X-Ray | Hemagglutinin Glycoproteins, Influenza Virus - immunology | Immunoglobulin Variable Region - immunology | Epitopes - immunology | Antibodies, Neutralizing - immunology | Influenza A virus - immunology | Influenza B virus - immunology | Orthomyxoviridae Infections - therapy | Protein Structure, Secondary | Cells, Cultured | Models, Molecular | Glycosylation | Ferrets | Antibodies, Viral - isolation & purification | Antibodies, Neutralizing - isolation & purification | Cross Reactions | Antigens, Viral - immunology | Animals | Hydrophobic and Hydrophilic Interactions | Immunization, Passive | Antibodies, Viral - immunology | Mice | Orthomyxoviridae Infections - immunology | Influenza, Human - immunology | Plasma Cells - immunology | Influenza viruses | Influenza vaccines | Monoclonal antibodies | Research | Properties | Vaccines | Influenza | Public health | Virology
Journal Article
Nature, ISSN 0028-0836, 2013, Volume 501, Issue 7467, pp. 439 - 443
Broadly neutralizing antibodies reactive against most and even all variants of the same viral species have been described for influenza and HIV-1 (ref. 1).... 
IN-VITRO | MEMORY B-CELLS | TRACT DISEASE | MULTIDISCIPLINARY SCIENCES | HUMAN METAPNEUMOVIRUS | FUSION PROTEIN | ELECTRON-MICROSCOPY | INFECTION | RESPIRATORY SYNCYTIAL VIRUS | YOUNG-CHILDREN | F-GLYCOPROTEIN | Humans | Immunoglobulin Variable Region - chemistry | Paramyxoviridae - classification | Pneumovirus Infections - prevention & control | Molecular Sequence Data | Antibodies, Monoclonal - therapeutic use | Immunoglobulin Variable Region - immunology | Respiratory Syncytial Virus Infections - immunology | Viral Fusion Proteins - immunology | Murine pneumonia virus - immunology | Epitopes - immunology | Immunoglobulin Light Chains - chemistry | Antibodies, Neutralizing - immunology | Antibody Specificity - immunology | Paramyxoviridae Infections - virology | Viral Fusion Proteins - chemistry | Cattle | Antibodies, Neutralizing - therapeutic use | Respiratory Syncytial Virus Infections - prevention & control | Respiratory Syncytial Virus, Bovine - immunology | Respiratory Syncytial Virus Infections - virology | Antibodies, Monoclonal - chemistry | Antibodies, Monoclonal - immunology | Immunoglobulin Light Chains - immunology | Amino Acid Sequence | Metapneumovirus - immunology | Paramyxoviridae Infections - therapy | Models, Molecular | Antibodies, Monoclonal - isolation & purification | Cross Reactions - immunology | Pneumovirus Infections - virology | Antibodies, Neutralizing - isolation & purification | Paramyxoviridae Infections - immunology | Pneumovirus Infections - immunology | Paramyxoviridae - immunology | Animals | Respiratory Syncytial Virus, Human - immunology | Antibodies, Neutralizing - chemistry | Viral Vaccines - chemistry | Mice | Paramyxoviridae Infections - prevention & control | Respiratory Syncytial Virus Infections - therapy | Viral Vaccines - immunology | Monoclonal antibodies | Paramyxoviruses | Control | Health aspects | Proteins | Competition | Viruses | Glycoproteins | Infections | Mutation
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 12/2014, Volume 111, Issue 50, pp. 17965 - 17970
Journal Article
Science, ISSN 0036-8075, 03/2016, Volume 351, Issue 6279, pp. 1339 - 1342
Journal Article
Nature, ISSN 0028-0836, 04/2017, Volume 544, Issue 7651, pp. 498 - 502
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2015, Volume 112, Issue 33, pp. 10473 - 10478
Journal Article
Vaccine, ISSN 0264-410X, 2015, Volume 33, Issue 17, pp. 2086 - 2095
Highlights • We used IgG1 and dimeric IgA2 versions of the V3-loop specific mAb HGN194. • HGN194 IgG1 given iv at a low dose to monkeys: 0% protection from... 
Allergy and Immunology | Rhesus monkey | IgA | 6 max | SHIV-C mucosal challenge | IgG | Complete protection | Passive immunization | VIRAL LOAD | MEDICINE, RESEARCH & EXPERIMENTAL | SHIV-C mucosal challenge (6 max) | PREVENTION | IMMUNOLOGY | AIDS VACCINE | 1-INFECTED INDIVIDUALS | IMMUNE-RESPONSES | HIV-1-INFECTED INDIVIDUALS | MACAQUES | INFECTION | MONOCLONAL-ANTIBODIES | VACCINE EFFICACY TRIAL | HIV Antibodies - blood | Antibodies, Neutralizing - administration & dosage | Immunoglobulin G - blood | Humans | Immunity, Mucosal | RNA, Viral - blood | Administration, Mucosal | Macaca mulatta | Immunoglobulin G - immunology | Antibodies, Monoclonal - immunology | Simian Immunodeficiency Virus - immunology | Simian Immunodeficiency Virus - pathogenicity | HIV Antibodies - administration & dosage | Immunoglobulin G - administration & dosage | Simian Acquired Immunodeficiency Syndrome - prevention & control | Administration, Intravenous | HIV-1 - immunology | Animals | Mucous Membrane - immunology | Simian Acquired Immunodeficiency Syndrome - immunology | Antibodies, Monoclonal - administration & dosage | Immunoglobulin A - immunology | Immunization, Passive | Immunoglobulin A - blood | T-Lymphocytes - immunology | Immunity, Cellular | Immunoglobulin A - administration & dosage | HIV (Viruses) | Immunoglobulin A | Immunoglobulin G | Medical research | Immunization | Vaccines | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV
Journal Article
EMBO Molecular Medicine, ISSN 1757-4676, 04/2016, Volume 8, Issue 4, pp. 407 - 421
Currently available rabies post‐exposure prophylaxis (PEP) for use in humans includes equine or human rabies immunoglobulins (RIG). The replacement of RIG with... 
rabies | post‐exposure prophylaxis | lyssaviruses | human monoclonal antibody | Post-exposure prophylaxis | Lyssaviruses | Rabies | Human monoclonal antibody | MEDICINE, RESEARCH & EXPERIMENTAL | LYSSAVIRUS | VIRUS | IMMUNE GLOBULIN | PREVENTION | VACCINE INOCULATIONS | COMBINATION | B-CELLS | BAT | DIFFERENT SCHEDULES | post-exposure prophylaxis | NEUTRALIZATION | Antibodies, Neutralizing - administration & dosage | Rabies - prevention & control | Immunization, Passive - methods | Rabies virus - immunology | Immunologic Factors - isolation & purification | Humans | Immunologic Factors - administration & dosage | Immunologic Factors - immunology | Post-Exposure Prophylaxis - methods | Treatment Outcome | Antibodies, Monoclonal - isolation & purification | Antibodies, Viral - isolation & purification | Antibodies, Neutralizing - isolation & purification | Antibodies, Neutralizing - immunology | Animals | Antibodies, Monoclonal - administration & dosage | Mesocricetus | Survival Analysis | Antibodies, Viral - immunology | Antibodies, Viral - administration & dosage | Antibodies, Monoclonal - immunology | Disease Models, Animal | Monoclonal antibodies | B cells | Hamsters | Vaccination | Antigenic determinants | Bats | Immunoglobulins | Memory cells | Immunological memory | Lymphocytes B | Prophylaxis | Viruses | Vaccines | Antibody response | Life Sciences | Microbiology and Parasitology | Virology | Immunology | Microbiology, Virology & Host Pathogen Interaction
Journal Article
Cell, ISSN 0092-8674, 07/2016, Volume 166, Issue 3, pp. 596 - 608
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 3, p. e18207
Journal Article